1.89
price down icon3.08%   -0.06
after-market Handel nachbörslich: 1.93 0.04 +2.12%
loading
Schlusskurs vom Vortag:
$1.95
Offen:
$1.92
24-Stunden-Volumen:
110.19K
Relative Volume:
0.46
Marktkapitalisierung:
$55.89M
Einnahmen:
$80.97M
Nettoeinkommen (Verlust:
$-78.31M
KGV:
-0.1705
EPS:
-11.0849
Netto-Cashflow:
$-129.56M
1W Leistung:
+6.18%
1M Leistung:
+8.00%
6M Leistung:
-11.27%
1J Leistung:
+3.28%
1-Tages-Spanne:
Value
$1.84
$1.94
1-Wochen-Bereich:
Value
$1.7971
$1.959
52-Wochen-Spanne:
Value
$1.325
$2.89

Fortress Biotech Inc Stock (FBIO) Company Profile

Name
Firmenname
Fortress Biotech Inc
Name
Telefon
781-652-4500
Name
Adresse
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
Name
Mitarbeiter
101
Name
Twitter
@fortressbio
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
FBIO's Discussions on Twitter

Vergleichen Sie FBIO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
FBIO
Fortress Biotech Inc
1.89 52.63M 80.97M -78.31M -129.56M -11.08
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-03-15 Fortgesetzt ROTH MKM Buy
2022-08-04 Eingeleitet Ladenburg Thalmann Buy
2020-10-02 Eingeleitet The Benchmark Company Buy
2019-12-18 Eingeleitet B. Riley FBR Buy
2018-02-28 Eingeleitet B. Riley FBR, Inc. Buy
2017-07-11 Eingeleitet Rodman & Renshaw Buy
2017-03-22 Eingeleitet JMP Securities Mkt Outperform
2016-10-03 Eingeleitet ROTH Capital Buy
Alle ansehen

Fortress Biotech Inc Aktie (FBIO) Neueste Nachrichten

pulisher
May 30, 2025

Sun Pharmaceutical Industries Completes Acquisition Of Checkpoint Therapeutics - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

Fortress Biotech Closes Sale of Checkpoint Therapeutics Unit - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

Fortress Biotech Announces Closing of Sale of Subsidiary Checkpo - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics | FBIO Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics - GlobeNewswire

May 30, 2025
pulisher
May 30, 2025

Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics - Benzinga

May 30, 2025
pulisher
May 30, 2025

Fortress Biotech Cashes In: $28M Upfront Plus Royalties in Strategic Checkpoint Sale to Sun Pharma - Stock Titan

May 30, 2025
pulisher
May 29, 2025

One Fortress Biotech Insider Raised Stake By 26% In Previous Year - simplywall.st

May 29, 2025
pulisher
May 28, 2025

Checkpoint Investor Sues for Info on Sale From Fortress to Sun - Bloomberg Law News

May 28, 2025
pulisher
May 27, 2025

New Strong Sell Stocks for May 16th - The Globe and Mail

May 27, 2025
pulisher
May 23, 2025

Q2 EPS Estimates for Fortress Biotech Raised by Roth Capital - Defense World

May 23, 2025
pulisher
May 22, 2025

How the (FBIOP) price action is used to our Advantage - news.stocktradersdaily.com

May 22, 2025
pulisher
May 22, 2025

Sun Pharma Q4 Consol Net PAT 21.5 Billion Rupees - marketscreener.com

May 22, 2025
pulisher
May 20, 2025

Fortress Biotech Reports Q1 2025 Financial Highlights - TipRanks

May 20, 2025
pulisher
May 17, 2025

Fortress Biotech First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 17, 2025
pulisher
May 16, 2025

Fortress Biotech Inc (FBIO) Reports Q1 2025 Revenue of $13.1M, S - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Fortress Biotech: Q1 Earnings Snapshot - CT Insider

May 16, 2025
pulisher
May 15, 2025

Fortress Biotech (FBIO) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Fortress Biotech, Inc. SEC 10-Q Report - TradingView

May 15, 2025
pulisher
May 15, 2025

Fortress Biotech Inc (FBIO) Reports Q1 2025 Revenue of $13.1M, Surpassing Estimates - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Fortress Biotech Reports First Quarter 2025 Financial Results an - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

Fortress Biotech Earnings: Triple Win with $28M Checkpoint Deal, FDA Fast-Track, and Rosacea Drug Launch - Stock Titan

May 15, 2025
pulisher
May 14, 2025

Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Fortress Biotech (FBIO) Projected to Post Quarterly Earnings on Wednesday - Defense World

May 14, 2025
pulisher
May 13, 2025

Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates - GlobeNewswire

May 13, 2025
pulisher
May 07, 2025

Fortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference | FBIO Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Fortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference - The Manila Times

May 07, 2025
pulisher
May 05, 2025

Renaissance Technologies LLC Has $356,000 Stock Holdings in Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World

May 05, 2025
pulisher
May 05, 2025

Fortress Biotech, Inc. (NASDAQ:FBIO) Stock Position Boosted by Envestnet Asset Management Inc. - Defense World

May 05, 2025
pulisher
May 03, 2025

Geode Capital Management LLC Increases Stock Position in Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World

May 03, 2025
pulisher
Apr 28, 2025

Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Acceptance and Priority Review of NDA for CUTX-101 for Treatment of Menkes Disease - The Globe and Mail

Apr 28, 2025
pulisher
Apr 22, 2025

Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - ADVFN

Apr 22, 2025
pulisher
Apr 21, 2025

Sun Pharma shares in focus as co to acquire Checkpoint Therapeutics for $355 million - MSN

Apr 21, 2025
pulisher
Apr 16, 2025

Fortress Biotech Board Member Resigns for New Role - TipRanks

Apr 16, 2025
pulisher
Apr 16, 2025

When the Price of (FBIOP) Talks, People Listen - news.stocktradersdaily.com

Apr 16, 2025
pulisher
Apr 15, 2025

Fortress Biotech (NASDAQ:FBIOP) Trading Down 2.1% – What’s Next? - Defense World

Apr 15, 2025
pulisher
Apr 09, 2025

This Fortress Biotech Insider Increased Their Holding By 26% Last Year - Yahoo Finance

Apr 09, 2025
pulisher
Apr 07, 2025

Roth Capital Forecasts Reduced Earnings for Fortress Biotech - Defense World

Apr 07, 2025
pulisher
Apr 04, 2025

FBIO FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important Tuesday Deadline in Securities Class ActionFBIO - MarketScreener

Apr 04, 2025
pulisher
Apr 01, 2025

SEC Form POS AM filed by Fortress Biotech Inc. - Quantisnow

Apr 01, 2025
pulisher
Apr 01, 2025

Journey Medical appoints new COO amid growth phase - Investing.com

Apr 01, 2025
pulisher
Mar 31, 2025

Fortress Biotech (FBIO) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Mar 31, 2025
pulisher
Mar 31, 2025

Fortress Biotech Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights - GlobeNewswire

Mar 31, 2025
pulisher
Mar 31, 2025

Fortress Biotech Transforms Portfolio: Dual FDA Wins, $28M Deal, Latest Earnings - Stock Titan

Mar 31, 2025
pulisher
Mar 29, 2025

Fortress Biotech, Inc. (NASDAQ:FBIO) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 29, 2025
pulisher
Mar 28, 2025

Fortress Biotech’s Mixed Earnings Call: Emrosi’s Launch and Challenges - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

Breakthrough: CKPT Secures FDA Approval and $416M Merger Deal in Transformative Year - Stock Titan

Mar 28, 2025
pulisher
Mar 28, 2025

MUSTANG BIO, INC. SEC 10-K Report - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

Journey Medical Reports 2024 Financial Results - TipRanks

Mar 28, 2025

Finanzdaten der Fortress Biotech Inc-Aktie (FBIO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
Kapitalisierung:     |  Volumen (24h):